Therefore, tumor cells with defective HR, such as those with a BRCA1/2 mutation, are susceptible to impairment of PARP, facilitating cell death, or can be alternatively repaired by the error-prone NHEJ pathway, resulting in genomic instability before cell death (24, 25). This evidence concerns the gene BRCA1 and neoplasm.